Hannah Kibuuka

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 334 citations · Full text

Vaccination, Vaccine Development, Nhp 13-19 +9

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

Dan H. Barouch, Sandra V. Kik, Gerrit Jan Weverling et al. · Vaccine · 2011 · 302 citations

Diagnostic Virology, Viral Diagnostics, International Seroepidemiology +5

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

Merlin L. Robb, Leigh Anne Eller, Hannah Kibuuka et al. · New England Journal of Medicine · 2016 · 281 citations · Full text

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

Danielle V. Clark, Hannah Kibuuka, Monica Millard et al. · The Lancet Infectious Diseases · 2015 · 225 citations · Full text

Virus Epidemiology, Long-term Sequelae, Disease Outbreak +5

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

Hannah Kibuuka, Nina M. Berkowitz, Monica Millard et al. · The Lancet · 2014 · 125 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +9